Houston、TXにおけるうつ病の臨床試験
Houstonとその周辺地域（約30マイル以内）の拠点で、うつ病に関する18件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
被験者募集中第3相
- Brain Health Consultants and TMS Center, Houston
Gamma Oscillations as a Prognostic Marker for Ketamine Therapy in Treatment Resistant Depression
被験者募集中第1相健康なボランティア歓迎
- Wells Medicine, Houston
- Texas A&M (Houston Methodist Hospital Location), Houston
Psilocybin-Assisted Psychotherapy in Patients With Advanced Cancer on Maintenance Therapy
被験者募集中第2相
- MD Anderson Cancer Center, Houston
PCORI Comparative Effectiveness Study-Esketamine (Spravato) vs. Ketamine-Equivalence Study
被験者募集中第3相
- Houston Center for Advanced Psychiatric Treatment, Bellaire · 7マイル先
Neurodevelopmental Outcomes in Children: Strengthening the Caregiver-Child Story
被験者募集中観察研究健康なボランティア歓迎
- Texas Children's Hospital, Houston
Cognitive Training as an Adjunct to Ketamine in Real-world Clinics
被験者募集中
- Baylor College of Medicine, Houston
TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors
被験者募集中第2相
- The University of Texas M. D. Anderson Cancer Center, Houston
Bilateral Prefrontal and Insular TMS for Depression in Schizophrenia
被験者募集中
- The University of Texas Health Science Center at Houston, Houston
Telehealth Behavioral Activation for Teens
被験者募集中
- Baylor College of Medicine, Houston
A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.
被験者募集中第3相
- Kaleidoscope Clinical Research /ID# 277650, Houston
- Houston Clinical Trials - Bellaire /ID# 274189, Bellaire · 7マイル先
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
被験者募集中第3相
- Neurocrine Clinical Site, Houston
- Neurocrine Clinical Site, Bellaire · 7マイル先
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
被験者募集中
- The University Of Texas Medical School At Houston - UT Center Of Excellence On Mood Disorders, Houston
Transcutaneous Vagus Nerve Stimulation for Attention and Memory
被験者募集中
- Michael E. DeBakey VA Medical Center, Houston
- Michael E. DeBakey VA Medical Center, Houston
Self Neuro-modulation Therapy for Major Depressive Disorder (MDD) With Anhedonia
被験者募集中
- Houston Center For Advanced Psychiatric Treatment, Houston
Survivorship Care for Women Living With Ovarian Cancer: (POSTCARE-O)
被験者募集中
- Dan L Duncan Comprehensive Cancer Center at the O'Quinn Medical Tower at Baylor St. Luke's Medical Center, Houston
- Harris Health Smith Clinic, Houston
Intracranial Investigation of Neural Circuity Underlying Human Mood
被験者募集中
- Baylor College of Medicine, Houston
Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
被験者募集中第3相
- Neurocrine Clinical Site, Houston
Functional Connectivity Alterations in Suicidal Patients Among Opioid Users
被験者募集中健康なボランティア歓迎
- The Menninger Clinic, Houston
他の都市におけるうつ病の試験
- Boston, MA52件の研究
- New York City, NY45件の研究
- Philadelphia, PA26件の研究
- Atlanta, GA24件の研究
- Chicago, IL24件の研究
- Pittsburgh, PA22件の研究
- San Diego, CA21件の研究
- Charleston, SC19件の研究
- Orlando, FL17件の研究
- Los Angeles, CA17件の研究
- Miami, FL16件の研究
- Washington, DC15件の研究
Houstonにおける他の研究
- 非小細胞肺癌145件の研究
- 乳がん126件の研究
- がん（全種類）121件の研究
- 転移性癌104件の研究
- 大腸癌102件の研究
- 卵巣がん89件の研究
- 急性骨髄性白血病85件の研究
- 肺がん78件の研究
- 前立腺がん76件の研究
- 子宮内膜がん68件の研究
- 膵臓がん61件の研究
- 悪性黒色腫59件の研究
ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。